Zymosan

interleukin 6 ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 26949603 Inhibition of zymosan-induced cytokine and chemokine expression in human corneal fibroblasts by triptolide. 2016 1
2 25092526 Differential stimulation of peripheral blood mononuclear cells in Crohn's disease by fungal glycans. 2014 Dec 1
3 22116002 Identification of common secreted factors in human corneal fibroblasts exposed to LPS, poly(I:C), or zymosan. 2012 Mar 2
4 20107167 Release of interleukins 6 and 8 induced by zymosan and mediated by MAP kinase and NF-kappaB signaling pathways in human corneal fibroblasts. 2010 Jun 3
5 20224557 Toll-like receptor 6 Ser249Pro polymorphism is associated with lower left ventricular wall thickness and inflammatory response in hypertensive women. 2010 Jun 1
6 16501050 Coupling of C3bi to IgG inhibits the tyrosine phosphorylation signaling cascade downstream Syk and reduces cytokine induction in monocytes. 2006 May 1
7 17049124 Anti-inflammatory effects of a novel peptide designed to bind with NF-kappaB p50 subunit. 2006 Nov 1
8 14973543 An inflammation-inducible adenoviral expression system for local treatment of the arthritic joint. 2004 Apr 1
9 15196211 Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. 2004 Jul 1
10 12727366 HUVEC take up opsonized zymosan particles and secrete cytokines IL-6 and IL-8 in vitro. 2003 May 15 1
11 12225373 Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta. 2002 Sep 1
12 10824456 Generation of pro-inflammatory and anti-inflammatory cytokines in the gut in zymosan-induced peritonitis. 2000 Mar 1
13 9510942 Changes in soluble IL-6 receptor and IL-6 production by polymorphonuclear cells and whole blood cells of breast cancer patients. 1998 1
14 9495792 Microglial cytokine gene induction after irradiation is affected by morphologic differentiation. 1997 Nov-Dec 1
15 8326131 Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor. 1993 Jul 1 1